{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T18:24:11Z","timestamp":1781115851497,"version":"3.54.1"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2007,10,2]],"date-time":"2007-10-02T00:00:00Z","timestamp":1191283200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2007,11,19]]},"DOI":"10.1007\/s00417-007-0683-5","type":"journal-article","created":{"date-parts":[[2007,10,1]],"date-time":"2007-10-01T06:40:15Z","timestamp":1191220815000},"page":"115-119","source":"Crossref","is-referenced-by-count":60,"title":["Blockade of VEGFR3-signalling specifically inhibits lymphangiogenesis in inflammatory corneal neovascularisation"],"prefix":"10.1007","volume":"246","author":[{"given":"Felix","family":"Bock","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasmine","family":"Onderka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tina","family":"Dietrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bj\u00f6rn","family":"Bachmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bronislaw","family":"Pytowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claus","family":"Cursiefen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2007,10,2]]},"reference":[{"key":"683_CR1","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1038\/nature04480","volume":"438","author":"K Alitalo","year":"2005","unstructured":"Alitalo K, Tammela T, Petrova TV (2005) Lymphangiogenesis in development and human disease. Nature 438:946\u2013953","journal-title":"Nature"},{"key":"683_CR2","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/nm1078","volume":"10","author":"L Chen","year":"2004","unstructured":"Chen L et al (2004) Vascular endothelial growth factor receptor-3 mediates induction of corneal alloimmunity. Nat Med 10:813\u2013815","journal-title":"Nat Med"},{"key":"683_CR3","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1093\/jnci\/94.11.819","volume":"94","author":"Y He","year":"2002","unstructured":"He Y et al (2002) Suppression of tumor lymphangiogenesis and lymph node metastasis by blocking vascular endothelial growth factor receptor 3 signaling. J Natl Cancer Inst 94:819\u2013825","journal-title":"J Natl Cancer Inst"},{"key":"683_CR4","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/84643","volume":"7","author":"M Skobe","year":"2001","unstructured":"Skobe M et al (2001) Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis. Nat Med 7:192\u2013198","journal-title":"Nat Med"},{"key":"683_CR5","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1172\/JCI20465","volume":"113","author":"C Cursiefen","year":"2004","unstructured":"Cursiefen C et al (2004) VEGF-A stimulates lymphangiogenesis and hemangiogenesis in inflammatory neovascularization via macrophage recruitment. J Clin Invest 113:1040\u20131050","journal-title":"J Clin Invest"},{"key":"683_CR6","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1073\/pnas.95.2.548","volume":"95","author":"MG Achen","year":"1998","unstructured":"Achen MG et al (1998) Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4). Proc Natl Acad Sci USA 95:548\u2013553","journal-title":"Proc Natl Acad Sci USA"},{"key":"683_CR7","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1126\/science.276.5317.1423","volume":"276","author":"M Jeltsch","year":"1997","unstructured":"Jeltsch M et al (1997) Hyperplasia of lymphatic vessels in VEGF-C transgenic mice. Science 276:1423\u20131425","journal-title":"Science"},{"key":"683_CR8","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1002\/j.1460-2075.1996.tb00521.x","volume":"15","author":"V Joukov","year":"1996","unstructured":"Joukov V et al (1996) A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases. Embo J 15:1751","journal-title":"Embo J"},{"key":"683_CR9","doi-asserted-by":"crossref","first-page":"3566","DOI":"10.1073\/pnas.92.8.3566","volume":"92","author":"A Kaipainen","year":"1995","unstructured":"Kaipainen A et al (1995) Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development. Proc Natl Acad Sci USA 92:3566\u20133570","journal-title":"Proc Natl Acad Sci USA"},{"key":"683_CR10","doi-asserted-by":"crossref","first-page":"4762","DOI":"10.1093\/emboj\/20.17.4762","volume":"20","author":"T Makinen","year":"2001","unstructured":"Makinen T et al (2001) Isolated lymphatic endothelial cells transduce growth, survival and migratory signals via the VEGF-C\/D receptor VEGFR-3. Embo J 20:4762\u20134773","journal-title":"Embo J"},{"key":"683_CR11","doi-asserted-by":"crossref","unstructured":"Schoppmann SF et al (2006) Hypoxia inducible factor-1alpha correlates with VEGF-C expression and lymphangiogenesis in breast cancer. Breast Cancer Res Treat","DOI":"10.1007\/s10549-006-9190-3"},{"key":"683_CR12","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/S0002-9440(10)64255-1","volume":"161","author":"SF Schoppmann","year":"2002","unstructured":"Schoppmann SF et al (2002) Tumor-associated macrophages express lymphatic endothelial growth factors and are related to peritumoral lymphangiogenesis. Am J Pathol 161:947\u2013956","journal-title":"Am J Pathol"},{"key":"683_CR13","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S0002-9440(10)65583-6","volume":"153","author":"A Lymboussaki","year":"1998","unstructured":"Lymboussaki A et al (1998) Expression of the vascular endothelial growth factor C receptor VEGFR-3 in lymphatic endothelium of the skin and in vascular tumors. Am J Pathol 153:395\u2013403","journal-title":"Am J Pathol"},{"key":"683_CR14","unstructured":"Cursiefen C (2007) Angiogenic and immune privilege. In: Niederkorn JY (ed) Ocular Immunology. Karger, New York (in press)"},{"key":"683_CR15","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.1167\/iovs.03-1380","volume":"45","author":"C Cursiefen","year":"2004","unstructured":"Cursiefen C et al (2004) Inhibition of hemangiogenesis and lymphangiogenesis after normal-risk corneal transplantation by neutralizing VEGF promotes graft survival. Invest Ophthalmol Vis Sci 45:2666\u20132673","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"683_CR16","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1097\/00003226-200304000-00021","volume":"22","author":"C Cursiefen","year":"2003","unstructured":"Cursiefen C et al (2003) Corneal lymphangiogenesis: evidence, mechanisms, and implications for corneal transplant immunology. Cornea 22:273\u2013281","journal-title":"Cornea"},{"key":"683_CR17","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/S0002-9440(10)62355-3","volume":"166","author":"C Cursiefen","year":"2005","unstructured":"Cursiefen C et al (2005) Spontaneous corneal hem- and lymphangiogenesis in mice with destrin-mutation depend on VEGFR3 signaling. Am J Pathol 166:1367\u20131377","journal-title":"Am J Pathol"},{"key":"683_CR18","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1097\/01.ico.0000183485.85636.ff","volume":"25","author":"C Cursiefen","year":"2006","unstructured":"Cursiefen C et al (2006) Time course of angiogenesis and lymphangiogenesis after brief corneal inflammation. Cornea 25:443\u2013447","journal-title":"Cornea"},{"key":"683_CR19","doi-asserted-by":"crossref","first-page":"11405","DOI":"10.1073\/pnas.0506112103","volume":"103","author":"C Cursiefen","year":"2006","unstructured":"Cursiefen C et al (2006) Nonvascular VEGF receptor 3 expression by corneal epithelium maintains avascularity and vision. Proc Natl Acad Sci USA 103:11405\u201311410","journal-title":"Proc Natl Acad Sci USA"},{"key":"683_CR20","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0002-9440(10)63630-9","volume":"163","author":"P Hamrah","year":"2003","unstructured":"Hamrah P et al (2003) Novel expression of vascular endothelial growth factor receptor (VEGFR)-3 and VEGF-C on corneal dendritic cells. Am J Pathol 163:57\u201368","journal-title":"Am J Pathol"},{"key":"683_CR21","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1172\/JCI23874","volume":"115","author":"K Maruyama","year":"2005","unstructured":"Maruyama K et al (2005) Inflammation-induced lymphangiogenesis in the cornea arises from CD11b-positive macrophages. J Clin Invest 115:2363\u20132372","journal-title":"J Clin Invest"},{"key":"683_CR22","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1167\/iovs.06-0783","volume":"48","author":"H Xu","year":"2007","unstructured":"Xu H et al (2007) LYVE-1-positive macrophages are present in normal murine eyes. Invest Ophthalmol Vis Sci 48:2162\u20132171","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"683_CR23","doi-asserted-by":"crossref","first-page":"361","DOI":"10.2353\/ajpath.2007.060896","volume":"171","author":"T Dietrich","year":"2007","unstructured":"Dietrich T et al (2007) Inhibition of inflammatory lymphangiogenesis by integrin {alpha}5 blockade. Am J Pathol 171:361\u2013372","journal-title":"Am J Pathol"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-007-0683-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00417-007-0683-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-007-0683-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T19:40:35Z","timestamp":1559072435000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00417-007-0683-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,10,2]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,11,19]]}},"alternative-id":["683"],"URL":"https:\/\/doi.org\/10.1007\/s00417-007-0683-5","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,10,2]]}}}